HIGHLIGHTS
- What: In this review, the authors explore the latest advances in histone modification research in prostate cancer, discussing their biological significance and potential implications for diagnosis and therapeutic strategies. This research provides a theoretical basis for considering JARID1D as a biomarker in advanced prostate cancer, helping to identify patients at higher risk for metastasis. The study suggests that this combination can be used to enhance the apoptotic response of prostate cancer cells, presenting a new avenue for targeted therapy.
- Who: Prostate Cancer and colleagues from the Department of Urology, Harbin Medical University Hospital, Harbin, Heilongjiang . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.